Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Drug Safety
|
March 9, 2004
Pregnancy exposure registries
Dianne L Kennedy, Kathleen Uhl, Sandra L Kweder
American Family Physician
|
June 27, 2003
Information on medication use in pregnancy
Kathleen Uhl, Dianne L Kennedy, Sandra L Kweder
Journal of Women'S Health (2002)
|
August 31, 2004
Complex clinical, legal, and ethical issues of pregnant and postpartum women as subjects in clinical trials
Kathleen Uhl, Margaret Ann Miller, Dianne L Kennedy
American Family Physician
|
March 5, 2003
Accurate information on drug effects on pregnancy is crucial
Kathleen Uhl, Dianne L Kennedy, Sandra L Kweder
Drug Safety
|
September 21, 2002
Risk management strategies in the Physicians' Desk Reference product labels for pregnancy category X drugs
Kathleen Uhl, Dianne L Kennedy, Sandra L Kweder
The Journal of Rheumatology
|
February 5, 2004
Disease modifying antirheumatic drugs and pregnancy
Kathleen Uhl, Dianne L Kennedy, William R Gilliland
Obstetrics and Gynecology
|
May 2, 2006
Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks
Gerard G Nahum, Kathleen Uhl, Dianne L Kennedy
The American Journal of Gastroenterology
|
April 8, 2010
Evolution of clinical trials for irritable bowel syndrome: issues in end points and study design
Ann Marie Trentacosti, Ruyi He, Laurie B Burke, et al.
Journal of the National Cancer Institute. Monographs
|
October 24, 2007
Challenges to use of health-related quality of life for Food and Drug Administration approval of anticancer products
Edwin P Rock, Jane A Scott, Dianne L Kennedy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2007
Patient-reported outcomes supporting anticancer product approvals
Edwin P Rock, Dianne L Kennedy, Melissa H Furness, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Drug Safety
|
March 9, 2004
Pregnancy exposure registries
Dianne L Kennedy, Kathleen Uhl, Sandra L Kweder
American Family Physician
|
June 27, 2003
Information on medication use in pregnancy
Kathleen Uhl, Dianne L Kennedy, Sandra L Kweder
Journal of Women'S Health (2002)
|
August 31, 2004
Complex clinical, legal, and ethical issues of pregnant and postpartum women as subjects in clinical trials
Kathleen Uhl, Margaret Ann Miller, Dianne L Kennedy
American Family Physician
|
March 5, 2003
Accurate information on drug effects on pregnancy is crucial
Kathleen Uhl, Dianne L Kennedy, Sandra L Kweder
Drug Safety
|
September 21, 2002
Risk management strategies in the Physicians' Desk Reference product labels for pregnancy category X drugs
Kathleen Uhl, Dianne L Kennedy, Sandra L Kweder
The Journal of Rheumatology
|
February 5, 2004
Disease modifying antirheumatic drugs and pregnancy
Kathleen Uhl, Dianne L Kennedy, William R Gilliland
Obstetrics and Gynecology
|
May 2, 2006
Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks
Gerard G Nahum, Kathleen Uhl, Dianne L Kennedy
The American Journal of Gastroenterology
|
April 8, 2010
Evolution of clinical trials for irritable bowel syndrome: issues in end points and study design
Ann Marie Trentacosti, Ruyi He, Laurie B Burke, et al.
Journal of the National Cancer Institute. Monographs
|
October 24, 2007
Challenges to use of health-related quality of life for Food and Drug Administration approval of anticancer products
Edwin P Rock, Jane A Scott, Dianne L Kennedy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2007
Patient-reported outcomes supporting anticancer product approvals
Edwin P Rock, Dianne L Kennedy, Melissa H Furness, et al.
Page
of 2